Aptevo Therapeutics Inc APVO shares are trading lower by after the company priced its $5 million public offering of 8,064,517 shares at 62 cents per share.
The 8,064,517 shares of common stock at $0.62 per share will be sold alongside Series A and Series B Warrants for the same number of shares.
The offering is expected to close on or around August 4, with anticipated gross proceeds of approximately $5 million, to be used for working capital purposes.
See Also: What's Going On With AMD Stock Wednesday?
According to data from Benzinga Pro, APVO has a 52-week high of $7.20 and a 52-week low of $0.58.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
